Khalid Alsabban1, Steven M Shea1, Amany Aziz1, Bryan Bisnaz2, Everardo Arias2, Ari Goldberg1, Gopal Gupta3, and Joseph H Yacoub1
1Radiology, Loyola University Medical Center, Maywood, IL, United States, 2Stritch School of Medicine, Maywood, IL, United States, 3Urology, Loyola University Medical Center, Maywood, IL, United States
Synopsis
The method of using an endorectal coil in a Prostate Magnetic Resonance
Imaging has been an area of debate between radiologists for some time now, with
a majority of research projects done to compare this method with the use of
phased array coils. In this retrospective project our main objective is to
identify if the temporary deforming effects caused by the use of the endorectal
coil in a Prostate Magnetic Resonance Imaging (MRI) procedure may affect biopsy
targeting. We will collect the dimensions measured by the MRI and compare it to
the dimensions measured using the Transrectal Ultrasound procedure (TRUS).Purpose:
The
method of using an
endorectal coil in prostate Magnetic Resonance Imaging (MRI) has been
an area of debate between radiologists for some time now. In this
retrospective project our main objective is to identify if the deforming
effects caused by the use of the endorectal coil
in a prostate MRI procedure may affect accuracy of biopsy targeting
using MR-US fusion biopsy technique. We will collect the dimensions
measured by MRI and Transrectal Ultrasound (TRUS) and use the difference
between the two as proxy for endorectal coil distortion.
We will then analyze if target misses occur significantly more when this difference is greatest.
Materials
and Methods:
In
this study we included 1) patients who had an
MRI with endorectal coil and then underwent targeted MR-US fusion
biopsy; and 2) had complete measurements on both MRI and TRUS. We
excluded 1) all cases when the MR target and TRUS biopsy results in the
same TRUS sextants were negative, since we are unable
to assume if the MR targeted biopsy was a miss or a hit; 2) patients
who underwent only an MR targeted biopsy or only a standard TRUS biopsy;
3) patients who did not have targets identified on MRI; and 4) patients
with incomplete measurements in the records.
A
target is considered a miss when the Gleason score of the target is
less than the Gleason score of the TRUS biopsy from the same sextant. A
target is considered
a hit if it had a higher or equal Gleason score than the TRUS from the
same sextant. In cases where two target lesions are identified in the
same TRUS sextant, we excluded the target with the higher Gleason score,
so as to assume a worst-case scenario for
target accuracy. We calculated the anteroposterior (AP) deformity which
is the difference in the measured AP dimension between MRI and TRUS.
We compared the AP difference between missed targets and hit targets.
A Mann-Whitney U test was used to test for statistical differences.
Note:
To verify our assumption that the AP difference in measurement between
the MRI and US represents deformity from the coil, we conducted a side
analysis comparing
the deformity of our study cases (129) which had the endorectal coil to
MRI cases that were performed without the endorectal coil and also had
MR-US fusion biopsy at our institution in the same time frame (8).
This side analysis confirmed that there was statistically
significant difference in the AP dimension between the endorectal cases
and the non endorectal cases (P<0.05). The difference in the
transverse dimension was not statistically significant and
therefore was not included in our analysis. The cranial-caudal
dimension was also not included based on our observation that US is
unreliable in assessing the superior extent of the prostate, as well as
the fact that our analysis evaluates the miss rate in
the axial plane.
Results:
We
started with a total of 229 patients, but this shrunk to 129 patients
(total targets = 206) after applying our exclusion criteria. 81 targets
were considered a hit while 9 targets were considered a miss. Fig. 1
shows
a box plot of AP dimension differences for each group.
Differences were not considered significant between the miss and hit groups (p= 0.154).
Discussion:
It is well observed that an
endorectal coil causes deformity in the prostate which we
estimated by the change in AP dimension between MRI and US. Our side
analysis comparing the AP change in cases using
endorectal coil to cases with no
endorectal coil suggest that this change is due at least in part to the
endorectal coil as opposed to modality difference. Our comparison
of “miss” and “hit” targets found no significant differences in the
deformity between the 2 groups suggesting that deformity caused by the
endorectal coil may not significantly affect the technical
success rate of the targeted biopsy. However, our data was limited by
the small number of missed targets. It is also possible that the true
miss rate
was underestimated since we were unable to compare against the true
gold standard, whole-mount prostatectomy pathology.
Conclusions:
We can conclude that the missed target rate is likely not affected by the deformity from
the endorectal coil.
Acknowledgements
No acknowledgement found.References
No reference found.